News Related to B Lymphocytes

Related coverage linked through entity extraction aliases.

Obinutuzumab Shows Efficacy in Systemic Lupus and Primary Membranous Nephropathy Trials

Mar 06, 2026

Obinutuzumab demonstrated superior efficacy in two separate phase 3 trials for systemic lupus erythematosus and primary membranous nephropathy, with statistically significant improvements in remission rates and disease response measures.

FDA Approves Acalabrutinib Plus Venetoclax for First-Line CLL and SLL Treatment

Feb 20, 2026

The FDA has approved the combination of acalabrutinib and venetoclax as the first all-oral, fixed-duration BTK inhibitor-based regimen for previously untreated adult patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.